The University also introduced a new 4+1 pathway for biomedical engineering undergraduates to earn a bachelor and master’s ...

Monday - Friday, 6:00 - 7:00 PM ET AstraZeneca CEO Pascal Soriot said artificial intelligence is helping the company develop medicines faster, identify promising drug targets, and improve the odds of ...

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning. By ...

Trying to get medicine approved by the US Food and Drug Administration often feels like buying an expensive lottery ticket, with the uncertain prospect of a reward years away. It takes about a decade ...

Researcher Jeffrey L. Cummings M.D., ScD, from the Kirk Kerkorian School of Medicine at UNLV, has released his annual report on the global effort to find a cure for Alzheimer's. The work is published ...

The National Drug Control Strategy is prepared biennially by the Office of National Drug Control Policy. This document provides a strategic roadmap for the Administration to continue dismantling the ...

LAUNCHING THE NATIONAL DRUG CONTROL STRATEGY: Today, President Trump’s Drug Czar Sara Carter released the National Drug Control Strategy. The Strategy is a road map for the United States to defeat the ...

Let’s start this story with a sing-along to the tune of “My Favorite Things.” Foundayo, Mounjaro, Zepbound and Ozempic. Skyrizi, Wegovy, Rinvoq and Dupixent. Tremfya, Jardiance, Nurtec ODT. These are ...

AWS has now unveiled Amazon Bio Discovery, an AI platform that grants researchers direct access to a broad library of biological foundation models that can be fine-tuned for specific use cases in drug ...

LONDON, April 14 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab, which has fallen behind Eli Lilly (LLY.N), opens new tab in the immensely lucrative weight-loss drug market, said ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.